It has been highlighted that p53 was mutated in >96% of high-grade serous ovarian carcinomas, mutant p53 contributed to ovarian cancer by promoting tumor differentiation, metastasis, and responsiveness to steroid hormones [62, 63]. Here, TP53 is linked to ovarian serous carcinoma.